TITLE

Anticholinergic drugs for COPD

AUTHOR(S)
Elliott, William T.
PUB. DATE
May 2011
SOURCE
Internal Medicine Alert;5/15/2011 Supplement, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on a study which shows the potential of anticholinergic drugs as first-line agents for the prevention of exacerbations in patients with chronic obstructive pulmonary disease (COPD).
ACCESSION #
62093056

 

Related Articles

  • Tiotropium beats LABA in COPD. Swan, David // Pulse;9/26/2012, Vol. 72 Issue 31, p14 

    The article presents a study according to which Tiotropium, an anticholinergic bronchodilator is more effective than a long-acting beta- agonist in preventing chronic obstructive pulmonary disease (COPD).

  • Inhaled Long-Acting β-Agonists Versus Anticholinergics in Older Patients With Chronic Obstructive Pulmonary Disease. Fabbri, Leonardo M.; Vogelmeier, Claus; Rabe, Klaus F.; Stanbrook, Matthew B.; Gershon, Andrea // Annals of Internal Medicine;10/18/2011, Vol. 155 Issue 8, p561 

    A letter to the editor is presented in response to the article "Comparison of inhaled long-acting β–agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study," by A. Gershon and colleagues in an issue of 2011 and a response...

  • Anticholinergic drugs for COPD. Elliott, William T. // Infectious Disease Alert;May2011 Clinical Bri, p1 

    The article reports on the findings of a study published in the "New England Journal of Medicine" in 2011 which emphasize the benefits of using the anticholinergic drug tiotropium over the beta-agonist salmeterol in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD).

  • Tiotropium for uncontrolled asthma.  // Neurology Alert;Dec2010 Supplement, p1 

    The article focuses on a study which investigated the therapeutic use of tiotropium, a long-acting anticholinergic inhaler, for patients with chronic obstructive pulmonary disease (COPD).

  • Tiotropium for Uncontrolled Asthma.  // Internal Medicine Alert;12/15/2010 Clinical Briefs, p1 

    The article reports on the findings of a study that suggest that tiotropium, a long-acting anticholinergic inhaler, has been approved for the treatment of chronic obstructive pulmonary disease.

  • Safety of Inhaled Anticholinergics for COPD Scrutinized.  // Internal Medicine Alert;10/29/2008 Pharmacology Watch, Vol. 30, p1 

    The article discusses the medical study which investigates the effects of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD).

  • Anticholinergic inhalers 'raise risk of CVD by 58%'. Tanday, Sanjay // GP: General Practitioner;9/26/2008, p8 

    The article offers information on the study conducted by the U.S. and Great Britain regarding the danger posed by anticholinergic inhalers to patients with chronic obstructive pulmonary disease (COPD). It was found that these patients are in danger of cardiovascular disease (CVD). Researchers...

  • New treatment for COPD launched.  // Pulse;9/9/2002, Vol. 62 Issue 34, p4 

    Announces the launch of Spiriva, an anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease by Boehringer Ingelheim and Pfizer in Great Britain.

  • Nipping it in the bud: An inspiring mission for prevention and management of COPD. Zhong, Nanshan // Journal of Thoracic Disease;Apr2012, Vol. 4 Issue 2, p102 

    The author discusses the challenges involved in early intervention, prevention and management of chronic obstructive pulmonary disorder (COPD). Several reasons for it include a lack of sensitive and specific indicators or markers for early diagnosis of COPD, the annual decline in forced...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics